Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 7 records, 1 pages
Search For: Favipiravir
Global Favipiravir Supply, Demand and Key Producers, 2024-2030
27 Feb 2024
Pharma & Healthcare
The global Favipiravir market size is expected to reach $ 67 million by 2030, rising at a market growth of -21.1% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Favipiravir Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Favipiravir market size was valued at USD 352.7 million in 2023 and is forecast to a readjusted size of USD 67 million by 2030 with a CAGR of -21.1% during review period.
USD3480.00
Add To Cart
Global Favipiravir Tablets Supply, Demand and Key Producers, 2024-2030
27 Feb 2024
Pharma & Healthcare
The global Favipiravir Tablets market size is expected to reach $ 2958.2 million by 2030, rising at a market growth of 4.4% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Favipiravir Tablets Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
06 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Favipiravir Tablets market size was valued at USD 2193.7 million in 2023 and is forecast to a readjusted size of USD 2958.2 million by 2030 with a CAGR of 4.4% during review period.
USD3480.00
Add To Cart
Global Favipiravir Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
18 Mar 2023
Pharma & Healthcare
Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. It is being developed and manufactured by Toyama Chemical (Fujifilm group) and was approved for medical use in Japan in 2014. In 2016, Fujifilm licensend API for it to Zhejiang Hisun Pharmaceutical Co. of China. It became a generic drug in 2019.
USD3480.00
Add To Cart
Global Favipiravir Tablets Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
27 Feb 2023
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Favipiravir Tablets market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
USD3480.00
Add To Cart
Global Favipiravir Tablets Supply, Demand and Key Producers, 2023-2029
06 Feb 2023
Pharma & Healthcare
The global Favipiravir Tablets market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
Search For: Favipiravir
Total: 7 records, 1 pages
The global Favipiravir market size is expected to reach $ 67 million by 2030, rising at a market growth of -21.1% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Favipiravir market size was valued at USD 352.7 million in 2023 and is forecast to a readjusted size of USD 67 million by 2030 with a CAGR of -21.1% during review period.
USD3480.00
Add To Cart
The global Favipiravir Tablets market size is expected to reach $ 2958.2 million by 2030, rising at a market growth of 4.4% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Favipiravir Tablets market size was valued at USD 2193.7 million in 2023 and is forecast to a readjusted size of USD 2958.2 million by 2030 with a CAGR of 4.4% during review period.
USD3480.00
Add To Cart
Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. It is being developed and manufactured by Toyama Chemical (Fujifilm group) and was approved for medical use in Japan in 2014. In 2016, Fujifilm licensend API for it to Zhejiang Hisun Pharmaceutical Co. of China. It became a generic drug in 2019.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Favipiravir Tablets market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
USD3480.00
Add To Cart
The global Favipiravir Tablets market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>